MRSN vs MTB · rev $40.5M vs P/E 12, rev $860.0M
Mersana Therapeutics Inc (MRSN) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
MRSN currently screens at market cap $145.4M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the MRSN and MTB stock pages for the full models.
Not investment advice.